Filtered By:
Source: Thrombosis and Haemostasis
This page shows you your search results in order of date. This is page number 6.
Order by Relevance | Date
Total 528 results found since Jan 2013.
Post-PCI Risk Assessment by Inflammation Activity According to Disease Acuity and Time from Procedure
CONCLUSION: AMI patients have greater inflammation during the early and late phases than non-AMI patients. Risk phenotype of hsCRPbaseline correlates with 1-month outcomes only in AMI patients. Whereas the prognostic implication of this risk phenotype appears similar during the late phase, irrespective of the disease acuity.PMID:36634702 | DOI:10.1055/a-2011-8426
Source: Thrombosis and Haemostasis - January 12, 2023 Category: Hematology Authors: Haegeun Song Jong-Hwa Ahn Min Gyu Kang Kye Hwan Kim Jae Seok Bae Sang-Yeong Cho Jin Sin Koh Yongwhi Park Seok-Jae Hwang Eun Jeong Cho Kyeongmin Byeon Sang-Wook Kim Udaya S Tantry Paul A Gurbel Jin-Yong Hwang Young-Hoon Jeong Source Type: research
Stroke and myocardial infarction in patients with abdominal aortic aneurysms and new-onset atrial fibrillation
Conclusion Cardiovascular prognosis has improved in patients with prevalent AAA disease and new-onset AF in concordance with optimization of antithrombotic therapy over time. A diagnosis of AF conferred residual risk of stroke and myocardial infarction.PMID:36626930 | DOI:10.1055/a-2009-8954
Source: Thrombosis and Haemostasis - January 10, 2023 Category: Hematology Authors: Chalotte Winther Winther Nicolajsen Peter Br ønnum Nielsen Martin Jensen Nikolaj Eldrup Torben Bjerregaard Larsen Gregory Yh Lip Samuel Z Goldhaber Mette S øgaard Source Type: research
Expression of microRNA Predicts Cardiovascular Events in Patients with Stable Coronary Artery Disease
CONCLUSIONS: Among patients with CAD, adding miR-223-3p expression to traditional cardiovascular risk factors may improve prediction of cardiovascular events, particularly ST. Clinical trials confirming these findings are warranted.PMID:36603835 | DOI:10.1055/s-0042-1760258
Source: Thrombosis and Haemostasis - January 5, 2023 Category: Hematology Authors: Oliver Buchhave Pedersen Erik Lerkevang Grove Peter H Nissen Sanne B øjet Larsen Leonardo Pasalic Steen Dalby Kristensen Anne-Mette Hvas Source Type: research
In CV disease, clopidogrel reduces nonfatal MI and MACE vs. aspirin but not stroke or mortality
Ann Intern Med. 2022 Dec 6. doi: 10.7326/J22-0094. Online ahead of print.NO ABSTRACTPMID:36469913 | DOI:10.7326/J22-0094
Source: Thrombosis and Haemostasis - December 5, 2022 Category: Hematology Authors: Akshay Goel Aaqib H Malik Source Type: research
Association between Platelet Count and Treatment Effect of Ticagrelor or Prasugrel in Patients with Acute Coronary Syndromes
CONCLUSIONS: In this analysis, incidence of ischemic and bleeding events at 12 months are comparable across quartiles of platelet count.PMID:36442805 | DOI:10.1055/a-1988-5047
Source: Thrombosis and Haemostasis - November 28, 2022 Category: Hematology Authors: Tobias Koch Shqipdona Lahu J J Coughlan Salvatore Cassese Felix Voll Gjin Ndrepepa Maurizio Menichelli Christian M Valina Rayyan Hemetsberger Bernhard Witzenbichler Isabell Bernlochner Michael Joner Erion Xhepa Katharina Mayer Thorsten Kessler Karl-Ludwig Source Type: research
Severe left atrial spontaneous echo contrast in non-valvular atrial fibrillation: Clinical characteristics and impact on ischemic risk post-ablation
Conclusions Higher BNP, ESR, LAd/∆LVED were the independent predictors for severe SEC. Severe SEC were associated with higher peri-procedural and long-term ischemic risks. ESR and LAd/∆LVED, as indicators of hematological and hemodynamic change, seemed helpful in identifying NVAF patients prone to developing severe SEC.PMID:36402133 | DOI:10.1055/a-1983-0516
Source: Thrombosis and Haemostasis - November 19, 2022 Category: Hematology Authors: Hao Wang Siqi Xi Jindong Chen Liang Zhao Tian Gan Ben He Source Type: research
